Heinz's cancer prognosis 'very good'
Teresa Heinz will remain active in her philanthropic work despite announcing she's being treated for breast cancer, the president of The Heinz Family Philanthropies said Wednesday.
"Her prognosis is very good," said Jeffrey R. Lewis, president of the foundation whose board Heinz chairs. "Nothing will stop her from continuing the work she's doing. Teresa has always been -- and will continue to be -- a fighter."
Heinz, 71, heiress to Heinz Co. fortune, said she learned in late September that she had Stage 1 breast cancer after having an annual mammogram. In early October, she underwent lumpectomies on both breasts -- surgical procedures to remove tumors.
The tests initially found cancer in her left breast, but doctors later found a malignant growth on her right breast. In November, Heinz had another pair of lumpectomies performed at Massachusetts General Hospital.
Heinz, who is married to Sen. John Kerry of Massachusetts, will undergo radiation next month. Heinz said the five days of targeted radiation should improve her odds of successful treatment to 95 percent.
In Stage 1 cancer, the cells have not spread beyond the breast or into lymph nodes, said Dr. Donald Keenan, a surgeon at West Penn Allegheny Health System. He is not involved in Heinz's treatment.
"At this stage of the disease, the majority of women can be cured," he said.
Compared with metastatic breast cancer -- which is incurable and has lower survival odds -- early-stage cancers can be treated before they have spread to other organs, Keenan said, emphasizing the importance of routine screenings such as mammograms.
Although Heinz has undergone required additional lumpectomies, it is not a sign for grave concern, Keenan said, noting that up to half the women who have lumpectomies return for second procedures.
Her case provides an opportunity to educate women about breast cancer, so they will not unnecessarily panic about their outlook, he said.
"Sometimes it takes more than one operation, and that doesn't mean the cancer is horrible," Keenan said. "It just means that it wasn't cleared the first time."
Heinz said she is undecided about follow-up treatment such as chemotherapy -- which could bump her survival odds to 99 percent -- because of her age and potential side effects.
"The benefit of finding it early means there's less likelihood a woman may need chemotherapy," Keenan said.
Some women choose hormone therapy, which can reduce the risk of cancer recurrence after surgery, he said.
Doug Root, communications director for The Heinz Endowments, said Heinz attended the foundation's board meetings in late October.
"She was actively getting treatment in the fall and, shortly after that, coming for the meetings," Root said.
Heinz has been outspoken about women's health issues for many years and will continue to be an advocate for breast-cancer issues and early detection, said Lewis of The Heinz Family Philanthropies.
"Her work in health care will continue for years to come, and her advocacy on behalf of women will only grow."
The Associated Press contributed to this story.
Show commenting policy
TribLive commenting policy
You are solely responsible for your comments and by using TribLive.com you agree to our Terms of Service.
We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.
While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.
We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers.
We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.
We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.
We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.
We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.